New drug combo shows promise for early anal cancer
Disease control
Recruiting now
This study tests whether adding the immunotherapy drug pembrolizumab to standard chemotherapy and radiation can improve outcomes for people with early-stage anal cancer. About 23 participants will receive the combination treatment, followed by maintenance therapy. The main goal i…
Phase: PHASE2 • Sponsor: Dustin Deming • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC